Article | March 25, 2022

The Added Value Of A Single Platform For Decentralized Clinical Trials

Source: Kayentis
Online Video Conference GettyImages-1325899588

DCTs are recognized as a necessary part of the new clinical trial paradigm. They respond to several of the long-lasting challenges that clinical trials stakeholders have been facing, such as patient enrollment and retention, patient compliance, data loss, data integrity, and data aggregation. Now is the time to switch to DCTs: patients are ready and the technology has evolved. But the success of DCTs requires operational caution and the integration of different systems. Although newly developed technologies support the implementation of DCTs, the accumulation of several layers can create significant complexity and can have an immediate negative impact on users. How can we be sure to build integrated systems that facilitate the utilization of these technologies, and as such drive patient and site engagement?

Why Switching to DCTs must happen now?

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader